Effect of heated humidified high-flow nasal cannula (HFNC) oxygen therapy in dyspnea patients with advanced cancer, a randomized controlled clinical trial
- PMID: 35984511
- DOI: 10.1007/s00520-022-07330-w
Effect of heated humidified high-flow nasal cannula (HFNC) oxygen therapy in dyspnea patients with advanced cancer, a randomized controlled clinical trial
Abstract
Purpose: Heated humidified high-flow nasal cannula (HFNC) oxygen therapy is one of the most important oxygen therapy methods, which are commonly applied to relieve dyspnea in advanced cancer patients. Our study aims to observe the efficacy and safety of HFNC oxygen therapy on dyspnea patients with advanced cancer and explore the clinical application.
Methods: Sixty subjects with advanced cancer requiring oxygen therapy from a grade 3, class A hospital in China were recruited and randomized (1:1) to traditional nasal catheter oxygen therapy or HFNC. Primary outcomes were dyspnea, oral dryness, and sleep condition, which were recorded after 72-h treatment. Secondary outcomes were heart rate (HR), respiration rate (RR), SpO2, PaO2, and PaCO2, which were recorded after 2, 6, 24, and 72 h treatment.
Results: Seventy-two hours after treatment, there were significant improvements in all primary outcomes (P < 0.001). PaO2 and RR were statistically changed 2 h after HFNC treatment (P < 0.001). PaCO2 and HR were statistically changed 24 h after HFNC treatment (P < 0.001).
Conclusion: HFNC oxygen therapy has good effect, high safety, and is easy to be accepted by dyspnea patients with advanced cancer. It can be used as the first choice of oxygen therapy for these patients and has broad clinical prospects.
Trial registration: This work was retrospectively registered in the Chinese Clinical Trials Registry (ChiCTR2100049582) on August 4, 2021.
Keywords: Dyspnea; Neoplasms; Oxygen inhalation therapy; Patient comfort; Randomized controlled trial.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients.J Pain Symptom Manage. 2024 Mar;67(3):204-211.e1. doi: 10.1016/j.jpainsymman.2023.11.009. Epub 2023 Nov 21. J Pain Symptom Manage. 2024. PMID: 37992848 Clinical Trial.
-
[Preliminary evaluation of sequential therapy by high flow nasal cannula oxygen therapy following endotracheal tube extubation in mechanically ventilated patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017 Sep;29(9):778-782. doi: 10.3760/cma.j.issn.2095-4352.2017.09.003. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28936951 Clinical Trial. Chinese.
-
High-flow nasal cannula oxygen therapy versus noninvasive ventilation for patients with blunt chest trauma: protocol for a randomized controlled trial.Trials. 2022 Jul 19;23(1):570. doi: 10.1186/s13063-022-06507-2. Trials. 2022. PMID: 35854391 Free PMC article.
-
High-flow nasal cannula versus conventional oxygen therapy in patients with dyspnea and hypoxemia before hospitalization.Expert Rev Respir Med. 2020 Apr;14(4):425-433. doi: 10.1080/17476348.2020.1722642. Epub 2020 Jan 30. Expert Rev Respir Med. 2020. PMID: 31985296 Review.
-
High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis.Intensive Care Med. 2019 May;45(5):563-572. doi: 10.1007/s00134-019-05590-5. Epub 2019 Mar 19. Intensive Care Med. 2019. PMID: 30888444
Cited by
-
Factors influencing nasal airway pressure and comfort in high-flow nasal cannula oxygen therapy: a volunteer study.BMC Pulm Med. 2023 Nov 20;23(1):449. doi: 10.1186/s12890-023-02752-6. BMC Pulm Med. 2023. PMID: 37985983 Free PMC article. Clinical Trial.
-
Current Management Options for Dyspnea in Cancer Patients.Curr Treat Options Oncol. 2023 Jun;24(6):565-579. doi: 10.1007/s11864-023-01081-4. Epub 2023 Apr 11. Curr Treat Options Oncol. 2023. PMID: 37037975 Review.
-
Oxygen therapy in acute hypoxemic respiratory failure: guidelines from the SRLF-SFMU consensus conference.Ann Intensive Care. 2024 Sep 5;14(1):140. doi: 10.1186/s13613-024-01367-2. Ann Intensive Care. 2024. PMID: 39235690 Free PMC article.
-
Comparative effectiveness of pharmacological and non-pharmacological interventions for dyspnea management in advanced cancer: A systematic review and network meta-analysis.Asia Pac J Oncol Nurs. 2025 Feb 18;12:100671. doi: 10.1016/j.apjon.2025.100671. eCollection 2025 Dec. Asia Pac J Oncol Nurs. 2025. PMID: 40129487 Free PMC article. Review.
-
Oxygen therapy and noninvasive respiratory supports in acute hypoxemic respiratory failure: a narrative review.Ann Intensive Care. 2024 Oct 18;14(1):158. doi: 10.1186/s13613-024-01389-w. Ann Intensive Care. 2024. PMID: 39419924 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
-
- Tishelman C, Petersson L-M, Degner LF et al (2007) Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death. J Clin Oncol 25:5381–5389. https://doi.org/10.1200/jco.2006.08.7874 - DOI - PubMed
-
- Maltoni M, Caraceni A, Brunelli C et al (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations — a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23:6240–6248. https://doi.org/10.1200/jco.2005.06.866 - DOI - PubMed
-
- Tanaka K, Akechi T, Okuyama T et al (2002) Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 23:417–423. https://doi.org/10.1016/s0885-3924(02)00376-7 - DOI - PubMed
-
- Gupta D, Lis CG, Grutsch JF (2007) The relationship between dyspnea and patient satisfaction with quality of life in advanced cancer. Support Care Cancer 15:533–538. https://doi.org/10.1007/s00520-006-0178-7 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical